Literature DB >> 9737929

A 2.8 A resolution structure of 6-phosphogluconate dehydrogenase from the protozoan parasite Trypanosoma brucei: comparison with the sheep enzyme accounts for differences in activity with coenzyme and substrate analogues.

C Phillips1, J Dohnalek, S Gover, M P Barrett, M J Adams.   

Abstract

The three-dimensional structure of 6-phosphogluconate dehydrogenase (6PGDH) from the parasitic protozoan Trypanosoma brucei has been solved at 2.8 A resolution. This pentose phosphate pathway enzyme is NADP-dependent; NADPH generated in the reaction protects against oxidative stress. The enzyme crystallises in the space-group P3121 with a dimer in the asymmetric unit and cell dimensions a=b=135.13 A, c=116.74 A, alpha=beta=90 degrees, gamma=120 degrees. The structure has refined to R=18.6% (Rfree=27.3%) with good geometry. The amino acid sequence of T. brucei 6PGDH is only 35% identical to that of the sheep liver enzyme and significant activity differences have been observed. The active dimer assembles with the C-terminal tail of one subunit threaded through the other, forming part of the substrate binding site. The tail of T. brucei 6PGDH is shorter than that of the sheep enzyme and its terminal residues associate tightly with the second monomer. The three-dimensional structure shows this generates additional interactions between the subunits close to the active site; the coenzyme binding domain is thereby associated more tightly with the helical domain. Three residues, conserved in all other known sequences, are important in creating a salt bridge between monomers close to the substrate binding site. The differences could explain the 200-fold enhanced affinity observed for the substrate analogue 6-phospho-2-deoxy-D-gluconate and suggest targets for anti-parasite drug design. The coenzyme binding domain of 6PGDH has a beta-alpha-beta fold; while in most species the "fingerprint" sequence is GxAxxG, in the T. brucei enzyme it is GxGxxG. Additional interactions between the enzyme and the coenzyme bis-phosphate are likely in the parasite 6PGDH, accounting for greater inhibition (40-fold) of 2'5'-ADP. While the core of the T. brucei dimer was restrained during refinement, several conformational differences have been found between the monomers; those at the coenzyme binding site suggest the molecule could be asymmetric during the enzyme reaction. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9737929     DOI: 10.1006/jmbi.1998.2059

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  16 in total

1.  Selective inhibition of 6-phosphogluconate dehydrogenase from Trypanosoma brucei.

Authors:  M Bertelli; E El-Bastawissy; M H Knaggs; M P Barrett; S Hanau; I H Gilbert
Journal:  J Comput Aided Mol Des       Date:  2001-05       Impact factor: 3.686

2.  Expression, crystallization and preliminary X-ray crystallographic analysis of glucose-6-phosphate dehydrogenase from the human pathogen Trypanosoma cruzi in complex with substrate.

Authors:  Cecilia Ortíz; Nicole Larrieux; Andrea Medeiros; Horacio Botti; Marcelo Comini; Alejandro Buschiazzo
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-10-27

3.  Crystal structures of a bacterial 6-phosphogluconate dehydrogenase reveal aspects of specificity, mechanism and mode of inhibition by analogues of high-energy reaction intermediates.

Authors:  Ramasubramanian Sundaramoorthy; Jorge Iulek; Michael P Barrett; Olivier Bidet; Gian Filippo Ruda; Ian H Gilbert; William N Hunter
Journal:  FEBS J       Date:  2007-01       Impact factor: 5.542

4.  6-Phosphogluconate dehydrogenase from Lactococcus lactis: a role for arginine residues in binding substrate and coenzyme.

Authors:  E Tetaud; S Hanau; J M Wells; R W Le Page; M J Adams; S Arkison; M P Barrett
Journal:  Biochem J       Date:  1999-02-15       Impact factor: 3.857

5.  Mechanism-based inhibition of the melatonin rhythm enzyme: pharmacologic exploitation of active site functional plasticity.

Authors:  E M Khalil; J De Angelis; M Ishii; P A Cole
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

6.  Targeting the Pentose Phosphate Pathway: Characterization of a New 6PGL Inhibitor.

Authors:  Anh Tuan Tran; Aude Sadet; Paolo Calligari; Philippe Lopes; Jamal Ouazzani; Matthieu Sollogoub; Emeric Miclet; Daniel Abergel
Journal:  Biophys J       Date:  2018-11-06       Impact factor: 4.033

7.  Identification, Cloning, and Characterization of l-Phenylserine Dehydrogenase from Pseudomonas syringae NK-15.

Authors:  Sakuko Ueshima; Hisashi Muramatsu; Takanori Nakajima; Hiroaki Yamamoto; Shin-Ichiro Kato; Haruo Misono; Shinji Nagata
Journal:  Enzyme Res       Date:  2010-03-25

8.  Virtual fragment screening for novel inhibitors of 6-phosphogluconate dehydrogenase.

Authors:  Gian Filippo Ruda; Gordon Campbell; Vincent P Alibu; Michael P Barrett; Ruth Brenk; Ian H Gilbert
Journal:  Bioorg Med Chem       Date:  2010-06-09       Impact factor: 3.641

9.  Defects in Peroxisomal 6-Phosphogluconate Dehydrogenase Isoform PGD2 Prevent Gametophytic Interaction in Arabidopsis thaliana.

Authors:  Christian Hölscher; Marie-Christin Lutterbey; Hannes Lansing; Tanja Meyer; Kerstin Fischer; Antje von Schaewen
Journal:  Plant Physiol       Date:  2016-03-03       Impact factor: 8.340

10.  Biochemical and structural insights into 6-phosphogluconate dehydrogenase from Leishmania donovani.

Authors:  Pranay Jakkula; Bandigi Narsimulu; Insaf Ahmed Qureshi
Journal:  Appl Microbiol Biotechnol       Date:  2021-07-12       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.